CVS Health Co. (NYSE:CVS) Shares Acquired by Aviance Capital Partners LLC

Aviance Capital Partners LLC increased its position in shares of CVS Health Co. (NYSE:CVS) by 6.5% during the 1st quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 11,669 shares of the pharmacy operator’s stock after acquiring an additional 710 shares during the period. Aviance Capital Partners LLC’s holdings in CVS Health were worth $931,000 at the end of the most recent quarter.

Several other institutional investors also recently bought and sold shares of CVS. Chapin Davis Inc. raised its stake in shares of CVS Health by 4.0% in the first quarter. Chapin Davis Inc. now owns 13,238 shares of the pharmacy operator’s stock valued at $1,056,000 after acquiring an additional 505 shares in the last quarter. Oak Asset Management LLC raised its position in CVS Health by 3.6% in the 1st quarter. Oak Asset Management LLC now owns 84,028 shares of the pharmacy operator’s stock valued at $6,702,000 after purchasing an additional 2,885 shares in the last quarter. LVW Advisors LLC acquired a new position in shares of CVS Health during the first quarter worth about $316,000. SteelPeak Wealth LLC purchased a new stake in shares of CVS Health during the first quarter worth approximately $1,475,000. Finally, Breakwater Capital Group raised its holdings in CVS Health by 7.1% in the first quarter. Breakwater Capital Group now owns 7,401 shares of the pharmacy operator’s stock valued at $590,000 after acquiring an additional 491 shares in the last quarter. 80.66% of the stock is owned by institutional investors and hedge funds.

Analysts Set New Price Targets

CVS has been the topic of a number of analyst reports. Barclays reduced their price objective on shares of CVS Health from $78.00 to $63.00 and set an “equal weight” rating on the stock in a report on Thursday, May 2nd. Cantor Fitzgerald reaffirmed a “neutral” rating and set a $58.00 price target on shares of CVS Health in a report on Wednesday, June 12th. Wells Fargo & Company cut their target price on CVS Health from $76.00 to $60.00 and set an “equal weight” rating on the stock in a research report on Tuesday, May 7th. Mizuho lowered their price target on CVS Health from $86.00 to $72.00 and set a “buy” rating for the company in a report on Thursday, May 2nd. Finally, Leerink Partnrs cut shares of CVS Health from an “outperform” rating to a “market perform” rating in a report on Wednesday, May 1st. Eleven investment analysts have rated the stock with a hold rating and thirteen have assigned a buy rating to the stock. According to MarketBeat, the company has an average rating of “Moderate Buy” and an average target price of $75.05.

CVS Health Stock Down 1.6 %

Shares of CVS Health stock opened at $58.14 on Tuesday. The company has a market cap of $72.99 billion, a P/E ratio of 10.22, a PEG ratio of 0.56 and a beta of 0.52. The firm has a fifty day moving average of $59.56 and a two-hundred day moving average of $70.13. The company has a debt-to-equity ratio of 0.78, a quick ratio of 0.61 and a current ratio of 0.81. CVS Health Co. has a one year low of $52.77 and a one year high of $83.25.

CVS Health (NYSE:CVS) last announced its quarterly earnings data on Wednesday, May 1st. The pharmacy operator reported $1.31 EPS for the quarter, missing analysts’ consensus estimates of $1.69 by ($0.38). The firm had revenue of $88.44 billion during the quarter, compared to analyst estimates of $89.33 billion. CVS Health had a net margin of 2.03% and a return on equity of 13.53%. CVS Health’s revenue for the quarter was up 3.7% on a year-over-year basis. During the same quarter in the previous year, the business earned $2.20 EPS. On average, analysts forecast that CVS Health Co. will post 7.02 earnings per share for the current year.

Insider Buying and Selling

In related news, Director Edward J. Ludwig purchased 1,000 shares of the stock in a transaction dated Thursday, May 2nd. The shares were acquired at an average cost of $53.88 per share, with a total value of $53,880.00. Following the purchase, the director now directly owns 21,630 shares in the company, valued at approximately $1,165,424.40. The acquisition was disclosed in a document filed with the SEC, which is available at this hyperlink. 0.24% of the stock is currently owned by corporate insiders.

About CVS Health

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.